3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
The potential of a spheroid tumor model composed of cells in different proliferative and metabolic states for the development of new anticancer strategies has been amply demonstrated. However, there is little or no information in the literature on the problems of reproducibility of data originating from experiments using 3D models. Our analyses, carried out using a novel open source software capable of performing an automatic image analysis of 3D tumor colonies, showed that a number of morphology parameters affect the response of large spheroids to treatment. In particular, we found that both spheroid volume and shape may be a source of variability. We also compared some commercially available viability assays specifically designed for 3D models. In conclusion, our data indicate the need for a pre-selection of tumor spheroids of homogeneous volume and shape to reduce data variability to a minimum before use in a cytotoxicity test. In addition, we identified and validated a cytotoxicity test capable of providing meaningful data on the damage induced in large tumor spheroids of up to diameter in 650 μm by different kinds of treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent progress has directed the development of high-throughput methods for uniform spheroid assembly and continuous perfusable culture that secure reproducibility [92].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commercial kits, such as CellTiter-Glo® 3D and Cultrex® 3D viability assays, are designed to enhance lysis efficiency and signal uniformity in spheroids [15,307].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [307]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
In VitroChondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3858 · Cited by 2,382
Optical Sectioning Deep Inside Live Embryos by Selective Plane Illumination Microscopy
Huisken, J., Swoger, J., Del Bene, F., Wittbrodt, J., & Stelzer, E. H. K. (2004) · Science · doi:10.1126/science.1100035 · Cited by 2,355
Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues
Baker, B. M., & Chen, C. S. (2012) · Journal of Cell Science · doi:10.1242/jcs.079509 · Cited by 1,760
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674
Three-dimensional culture models of normal and malignant breast epithelial cells
Lee, G. Y., Kenny, P. A., Lee, E. H., & Bissell, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1015 · Cited by 1,336 · cited 1×
“(5) The final volume is automatically estimated by counting the voxels bound by the surface and using the x-y pixel resolution coefficient to convert voxels to μ M3.”
MethodOpportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172
Spherical Cancer Models in Tumor Biology
Weiswald, L.-B., Bellet, D., & Dangles-Marie, V. (2015) · Neoplasia · doi:10.1016/j.neo.2014.12.004 · Cited by 1,141
Cited by
Items 501–600 of 1,000
Scomazzon, S. P., Riccio, A., Santopolo, S., Lanzilli, G., Coccia, M., Rossi, A., & Santoro, M. G. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0243 · Cited by 17
“Spheroid volume was calculated with ReViSP (21).”
MethodInfluentialSimão, D. F., Gomes, C. M., Alves, P. M., & Brito, C. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107883 · Cited by 17
In Vitro Human Cancer Models for Biomedical Applications
Choi, J. R., Kozalak, G., di Bari, I., Babar, Q., Niknam, Z., Rasmi, Y., & Yong, K. W. (2022) · Cancers · doi:10.3390/cancers14092284 · Cited by 17
Peltek, O. O., Игоревич, А. Э., Talianov, P. M., Mikushina, A. D., Epifanovskaya, O. S., Dubavik, A., Veiko, V. P., Lepik, K. V., Zuev, D. A., Timin, A. S., et al. (2022) · Nanophotonics · doi:10.1515/nanoph-2022-0314 · Cited by 17
“Tumor spheroids are commonly used in drug development since they can replicate physiological cell environment to a higher extent compared to the usual 2D cell culture [41, 57, 58].”
BackgroundPreclinical Models of Neuroblastoma—Current Status and Perspectives
Krawczyk, E., & Kitlinska, J. B. (2023) · Cancers · doi:10.3390/cancers15133314 · Cited by 17
Manoto, S. L., Houreld, N. N., Hodgkinson, N., & Abrahamse, H. (2017) · Molecules · doi:10.3390/molecules22050791 · Cited by 17
Jogalekar, M. P., & Serrano, E. E. (2018) · PeerJ · doi:10.7717/peerj.4340 · Cited by 17
“As a result, these 3D culturesmay provide a powerful platform for anti-cancer drug screening (Herrmann et al., 2014; Xu, Farach-Carson & Jia, 2014; Zanoni et al., 2016; Cavo et al., 2016).”
BackgroundMuddineti, O. S., Asmitha, V., Rompicharla, S. V. K., Kumari, P., Ghosh, B., & Biswas, S. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1435551 · Cited by 17
Bjelogrlić, S., Todorović, T. R., Cvijetić, I., Rodić, M. V., Vujčić, M. T., Marković, S. B., Araškov, J. B., Janović, B. S., Emhemmed, F., Muller, C. D., et al. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.10.002 · Cited by 17
Chew, D., Green, V., Riley, A., England, R. J., & Greenman, J. (2020) · Frontiers in Surgery · doi:10.3389/fsurg.2020.00043 · Cited by 17
Hong, C.-E., & Lyu, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101258 · Cited by 17
Thermosensitive Polymeric Nanoparticles for Drug Co-Encapsulation and Breast Cancer Treatment
Dartora, V. F. C., Passos, J. S., Costa-Lotufo, L. V., Lopes, L. B., & Panitch, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020231 · Cited by 16
Lee, S., Lee, E., Lim, J. U., Ku, B., Seong, Y.-J., Ryu, J.-O., Cho, H. J., Kim, K., Hwang, Y., Moon, S. W., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00890 · Cited by 16
Grimm, D. G., Corydon, T. J., Sahana, J., González-Torres, L. F., Kraus, A., Marchal, S., Wise, P. M., Simonsen, U., & Krüger, M. (2025) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szaf008 · Cited by 16
“…though the hanging drop method and liquid overlay technique allow for the generation of uniform spheroids, which can be used in high-throughput drug screening 75,76 they are labor-intensive for large-scale production, 77 resulting in low-throughput fabrication and variation in the spheroid sizes.”
Ma, C., Zhuang, J., Jia, J., Li, B., He, Y., Huo, L., Li, N., & Zhao, N. (2025) · Small · doi:10.1002/smll.202503994 · Cited by 16
Mishriki, S., Aithal, S., Gupta, T., Sahu, R. P., Geng, F., & Puri, I. K. (2020) · Research · doi:10.34133/2020/3970530 · Cited by 17
“Regulating the formation of these 3D cellular structures is critical for a drug discovery process [6, 16, 19, 20].”
BackgroundLee, J. H., Park, S., Hwang, W., Sung, J. Y., Cho, M., Shim, J., Kim, Y.-N., & Yoon, K. (2020) · Biomolecules · doi:10.3390/biom10111521 · Cited by 16
Sargenti, A., Musmeci, F., Cavallo, C., Mazzeschi, M., Bonetti, S., Pasqua, S., Bacchi, F., Filardo, G., Gazzola, D., Lauriola, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252907 · Cited by 16
Self-citationMammalian Cell Spheroids on Mixed Organic–Inorganic Superhydrophobic Coating
Ferrari, M., Cirisano, F., & Morán, M. C. (2022) · Molecules · doi:10.3390/molecules27041247 · Cited by 16
Gallegos-Martínez, S., Lara-Mayorga, I. M., Samandari, M., Mendoza-Buenrostro, C., Flores-Garza, B. G., Reyes‐Cortés, L. M., Segoviano-Ramírez, J. C., Zhang, Y. S., Santiago, G. T., & Álvarez, M. M. (2022) · Biofabrication · doi:10.1088/1758-5090/ac61a4 · Cited by 16
Geometric tumor embolic budding characterizes inflammatory breast cancer
Modi, A. P., Nguyen, J. P. T., Wang, J. Q., Ahn, J. S., Libling, W. A., Klein, J., Mazumder, P., & Barsky, S. H. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06819-6 · Cited by 16
Adult Stem Cells and Anticancer Therapy
Kalvelytė, A. V., Imbrasaitė, A., Krestnikova, N., & Stulpinas, A. (2017) · Advances in molecular toxicology · doi:10.1016/b978-0-12-812522-9.00004-x · Cited by 16
Askes, S. H. C., Bossert, N., Bussmann, J., Talens, V. S., Meijer, M. S., Kieltyka, R. E., Kros, A., Bonnet, S., & Heinrich, D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.037 · Cited by 16
Cornett, A. M., Athwal, H. K., Hill, E., Murphy, G. F., Yeoh, K., Moskaluk, C. A., Witt, R. L., D’Silva, N. J., Agarwal, S., & Lombaert, I. M. A. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.011 · Cited by 16
“For those ‘personalized medicine’-intended purposes, the creation of ex vivo 3D tumor spheroids in multi-well plates [37] can serve as a reliable method for rapid drug screening assays.”
MethodSun, P., Yang, S., Xuehui, S., Wang, Y., Jia, Y., Shang, P., Tian, H., Li, G., Li, R., Zhang, X., et al. (2019) · Polymers · doi:10.3390/polym11060959 · Cited by 16
Rodríguez, M. E., Rizzi, M., Caeiro, L. D., Masip, Y. E., Perrone, A. E., Sánchez, D. O., Búa, J., & Tekiel, V. (2020) · Cellular Microbiology · doi:10.1111/cmi.13207 · Cited by 16
The application of three-dimensional cell culture in clinical medicine
Chen, Q., & Wang, Y. (2020) · Biotechnology Letters · doi:10.1007/s10529-020-03003-y · Cited by 16
Kulwatno, J., Gearhart, J., Gong, X., Herzog, N. L., Getzin, M., Skobe, M., & Mills, K. L. (2021) · Integrative Biology · doi:10.1093/intbio/zyaa024 · Cited by 16
Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors
Haga, Y., Marrocco, I., Noronha, A., Uribe, M. L., Nataraj, N. B., Sekar, A., Garcia, D. D., Borgoni, S., Lindzen, M., Giri, S., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3555 · Cited by 16
Wang, Z., Himanen, S. V., Haikala, H. M., Friedel, C. C., Vihervaara, A., & Barborič, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad792 · Cited by 15
“Namely, spheroid cultures have emerged as a viable pre-clinical platform for evaluating anti-cancer treatments (84).”
BackgroundKim, J. Y., Shin, J. H., Kim, M.-J., Choi, B., Kang, Y., Choi, J., Kim, S. H., Kwan, D., Kim, D.-H., Chun, E., et al. (2024) · Biomarker Research · doi:10.1186/s40364-024-00604-x · Cited by 15
Parakhonskiy, B. V., Novoselova, M. V., Gorin, D. A., & Abalymov, A. A. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102534 · Cited by 15
Mátis, G., Sebők, C., Horváth, D. G., Márton, R. A., Mackei, M., Vörösházi, J., Kemény, Á., Neogrády, Z., Varga, I., & Tráj, P. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1484333 · Cited by 15
Balkrishna, A., Gohel, V., Kumari, P., Manik, M., Bhattacharya, K., Dev, R., & Varshney, A. (2022) · Bioengineered · doi:10.1080/21655979.2022.2065789 · Cited by 15
Seabra, R., Malhão, F., Correia, A., Costa, C., Kijjoa, A., & Rocha, E. (2023) · Marine Drugs · doi:10.3390/md21030166 · Cited by 15
“In spheroids, as described for solid tumors, the inner cells have lower oxygen availability, dependent on its diffusion throughout the spheroid/tumor and its consumption by the outer cells [70].”
BackgroundCell Viability Assay with 3D Prostate Tumor Spheroids
Öner, E., Gray, S. G., & Finn, S. P. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3056-3_17 · Cited by 15
The role of cell-matrix adhesion and cell migration in breast tumor growth and progression
Chong, L. H., Yip, A. K., Farm, H. J., Mahmoud, L. N., Zeng, Y., & Chiam, K. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1339251 · Cited by 15
Mesenchymal Stem Cells Relevance in Multicellular Bioengineered 3D In Vitro Tumor Models
Ferreira, L. P., Gaspar, V. M., Henrique, R., Jerónimo, C., & Mano, J. F. (2017) · Biotechnology Journal · doi:10.1002/biot.201700079 · Cited by 15
“The existence of ECM creates a suitable in vitro environment for testing and studying new pharmacological therapies and mimics in vivo conditions [65].”
Chen, H., Wei, X., Chen, H., Wei, H., Wang, Y., Nan, W., Zhang, Q., & Wen, X. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1544142 · Cited by 15
Computational Models Accurately Predict Multi-Cell Biomarker Profiles in Inflammation and Cancer
Fischer, C. L., Bates, A. M., Lanzel, E. A., Guthmiller, J. M., Johnson, G. K., Singh, N. K., Kumar, A., Vidva, R., Abbasi, T., Vali, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47381-4 · Cited by 15
Toxicity Assessment of Nanomaterials
Tasso, M., Huvelle, M. A. L., Bessone, I. D., & Picco, A. S. (2020) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-030-39923-8_13 · Cited by 15
Organoids as Complex In Vitro Models for Studying Radiation-Induced Cell Recruitment
Hacker, B. C., & Rafat, M. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00625-0 · Cited by 15
Khanna, S., Chauhan, A., Bhatt, A. N., & Dwarakanath, B. S. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-811710-1.00011-2 · Cited by 15
Tumor in 3D: In Vitro Complex Cellular Models to Improve Nanodrugs Cancer Therapy
Fernandes, S., Cassani, M., Pagliari, S., Filipenský, P., Cavalieri, F., & Forte, G. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200625151134 · Cited by 15
Li, C.-Y., Torres, V. C., He, Y.-S. J., Xu, X., Basheer, Y., Papavasiliou, G., Samkoe, K., Brankov, J., & Tichauer, K. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01587-z · Cited by 14
Tumor spheroid-based microtumor models for preclinical evaluation of anticancer nanomedicines
Khawar, I. A., Ghosh, T., Park, J. K., & Kuh, H. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00534-y · Cited by 15
Unsung versatility of elastin-like polypeptide inspired spheroid fabrication: A review
Goel, R., Gulwani, D., Upadhyay, P., Sarangthem, V., & Singh, T. D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123664 · Cited by 15
Assessing drug response in engineered brain microenvironments
Tate, K. M., & Munson, J. M. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.04.027 · Cited by 15
Single-cell light-sheet fluorescence 3D images of tumour-stroma spheroid multicultures
Diósdi, Á., Piccinini, F., Böröczky, T., Dobra, G., Castellani, G., Buzás, K., Horváth, P., & Harmati, M. (2025) · Scientific Data · doi:10.1038/s41597-025-04832-0 · Cited by 15
Self-citationGeneration of a Three-Dimensional In Vitro Ovarian Cancer Co-culture Model for Drug Screening Assays
Tofani, L. B., Sousa, L. O., Luiz, M. T., Abriata, J. P., Marchetti, J. M., Leopoldino, A. M., & Swiech, K. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.04.003 · Cited by 14
Tevlek, A. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad2378 · Cited by 14
“In terms of sphericity index values, tumor aggregates may be categorized as spherical (SI ⩾ 0.90) or non-spherical (SI ⩽ 0.90), with the latter classified into ellipsoidal, ‘8’-shaped, and irregular shapes [55].”
BackgroundInfluentialChaudhary, U., Kumar, P., Sharma, P., Chikara, A., Barua, A., Mahiya, K., Subin, J. A., Yadav, P. N., & Pokharel, Y. R. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107872 · Cited by 14
Optimization of Antiproliferative Properties of Triimine Copper(II) Complexes
Choroba, K., Zowiślok, B., Kula, S., Machura, B., Maroń, A. M., Erfurt, K., Marques, C., Cordeiro, S. Z., Baptista, P. V., & Fernandes, A. R. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01806 · Cited by 14
Phytochemicals in Breast Cancer Prevention and Therapy: Mechanisms, Efficacy, and Future Prospects
Kodali, N., Madu, C. O., & Lu, Y. W. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070527 · Cited by 14
“3D spheroids, organoids, patient-derived xenografts (PDXs), and other advanced models provide more physiologically relevant systems for studying the anticancer effects of phytochemicals [76].”
Organ‐on‐a‐Chip Technology and Global Multi‐Omics: Current Applications and Future Directions
Cao, X., Xia, C., Li, C., Deng, S., Cao, J., Yang, H., Wang, S., & Chen, P. (2026) · MedComm · doi:10.1002/mco2.70603 · Cited by 14
Issues with Cancer Spheroid Models in Therapeutic Drug Screening
Fröhlich, E. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200218094200 · Cited by 14
3D HeLa spheroids as a model for investigating the anticancer activity of Biginelli-hybrids
Crnogorac, M. Đ., Matić, I. Z., Damjanović, A., Janković, N., Krivokuća, A., & Stanojković, T. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109565 · Cited by 14
Hong, S., & Song, J. M. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c17877 · Cited by 14
Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models
Davy, M., Genest, L., Legrand, C., Pelouin, O., Froget, G., Castagné, V., & Rupp, T. (2023) · Cancers · doi:10.3390/cancers15184478 · Cited by 14
“The 3D tumor spheroids mimic some aspects of the cell–cell interaction, hypoxia, or molecular heterogeneity of tumors [61,62], which are not reproduced by 2D cell culture [63], making spheroids more relevant models.”
BackgroundMeier-Hubberten, J. C., & Sanderson, M. P. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9145-7_11 · Cited by 14
Schoos, A., Knab, V. M., Gabriel, C., Tripolt, S., Wagner, D. A., Bauder, B., Url, A., & Fux, D. A. (2019) · Veterinary and Comparative Oncology · doi:10.1111/vco.12514 · Cited by 14
Depping, R., von Fallois, M., Landesman, Y., & Kosyna, F. K. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s213208 · Cited by 14
Adams, J., Casali, A., & Campbell, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105101 · Cited by 14
Lee, D. W., Kim, J. E., Lee, G.-H., Son, A., Park, H. C., Oh, D., Jo, K., & Choi, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020587 · Cited by 14
Super Liquid-repellent Surfaces and 3D Spheroids Growth
Ferrari, M., Cirisano, F., & Morán, M. C. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2705144 · Cited by 14
“In addition, due to diffusional limitations, the larger spheroids would show lower proliferation capability [91] and accumulate carbon dioxide and metabolic reaction products as lactate in their inner regions [92].”
BackgroundIn vitro study of glyphosate effects on thyroid cells
Coperchini, F., Greco, A., Croce, L., Denegri, M., Magri, F., Rotondi, M., & Chiovato, L. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120801 · Cited by 14
Refractive index measurement of suspended cells using opposed-view digital holographic microscopy
Zheng, J., Gao, P., Shao, X., & Nienhaus, G. U. (2017) · Applied Optics · doi:10.1364/ao.56.009000 · Cited by 14
Liu, R., Zhao, T., Swat, M., Reynoso, F. J., & Higley, K. A. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1642537 · Cited by 14
“…that multicellular spheroids strongly resemble solid tumor morphology and general behavior, thus making them a valid model not only for radiation studies but also for fundamental research in cell biology and cancer ( Culo et al. 1980; Santini et al. 1999; Harting et al. 2009; Zanoni et al. 2016).”
BackgroundExploiting tumor hypoxia for cancer treatment
Niemans (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180626rn · Cited by 14
Fucina, G., Cesca, K., Berti, F. V., Biavatti, M. W., & Porto, L. M. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130183 · Cited by 13
A dual-luciferase bioluminescence system for the assessment of cellular therapies
Chavez, A. G. T., McKenna, M. K., Balasubramanian, K., Riffle, L. A., Patel, N. L., Kalen, J. D., Croix, B. S., Leen, A. M., & Bajgain, P. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200763 · Cited by 13
Kim, D., Heo, J., Song, B., Lee, G., Hong, C., Jiang, Z., Lee, S., Lee, K., Kim, M., & Park, M. H. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101061 · Cited by 13
“To date, much research has been developed for drug testing based on single or multicellular organisms [14,15].”
BackgroundMarco, A., Kašpárková, J., Bautista, D. K. M., Kostrhunová, H., Cutillas, N., Marková, L., Novohradský, V., Ruiz, J., & Brabec, V. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02357 · Cited by 13
Live-cell imaging and analysis of 3D spheroids in hypoxia- and radiotherapy-related research
Beckers, C., Vasilikos, L., Moor, L., & Pruschy, M. N. (2025) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2025.100920 · Cited by 13
“There is thus an urgent need for more efficient and standardized tools to explore treatment options that can overcome hypoxia-induced radioresistance at the preclinical level to ensure a more successful translation into the clinics [3,11,12].”
Cristini, N., Tavakoli, M., Sanati, M., & Yavari, S. A. (2025) · Journal of bone oncology · doi:10.1016/j.jbo.2025.100698 · Cited by 13
“These features, along with restricted drug diffusion, make MTS more physiologically relevant than traditional 2D cultures [104,105].”
Modeling the Bone Marrow Niche in Multiple Myeloma: From 2D Cultures to 3D Systems
Bottaro, A., Nasso, M. E., Stagno, F., Fazio, M., & Allegra, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136229 · Cited by 14
Meng, X., Xu, Y., & Ning, X. (2021) · Journal of Cell Science · doi:10.1242/jcs.255349 · Cited by 13
Human brain organoids in Alzheimer’s disease
Kang, Y. J., & Cho, H. (2021) · Organoid · doi:10.51335/organoid.2021.1.e5 · Cited by 13
An Improved Scalable Hydrogel Dish for Spheroid Culture
Valdoz, J. C., Jacobs, D. J., Cribbs, C. G., Johnson, B. C., Hemeyer, B. M., Dodson, E. L., Saunooke, J. A., Franks, N. A., Poulson, P. D., Garfield, S. R., et al. (2021) · Life · doi:10.3390/life11060517 · Cited by 13
Cancer‑associated fibroblasts as cellular vehicles in endometrial cancer cell migration
Voon, Y., Omar, I. S., Wu, M., Said, N. A. B. M., & Chung, I. (2021) · Oncology Letters · doi:10.3892/ol.2021.13121 · Cited by 13
Barot, S., Stephenson, O. J., Vemana, H. P., Yadav, A., Bhutkar, S. P., Trombetta, L. D., & Dukhande, V. V. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115201 · Cited by 13
Alves, R. F., Rocha, E., & Madureira, T. V. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109470 · Cited by 13
Sulaiman, A. A. A., Casagrande, N., Borghese, C., Corona, G., Isab, A. A., Ahmad, S., Aldinucci, D., & Altaf, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00737 · Cited by 13
Keeratichamroen, S., Sornprachum, T., Ngiwsara, L., Ornnork, N., & Svasti, J. (2023) · Oncology Reports · doi:10.3892/or.2023.8508 · Cited by 13
“As a consequence, numerous novel chemotherapeutic agents, that show promising results in 2D culture, fail during clinical trials (31,32).”
Three-Dimensional Spheroids for Cancer Research
Tutty, M. A., & Prina‐Mello, A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3056-3_3 · Cited by 13
Gao, Y., Bissoyi, A., Kinney, N. L. H., Whale, T. F., Guo, Q., & Gibson, M. I. (2023) · Chemical Communications · doi:10.1039/d3cc02252h · Cited by 13
Zhu, Q., He, X., Liu, J., Wang, H., Shan, X., Song, G., Zhang, L., Zhao, Y., & Yin, X. (2024) · Communications Biology · doi:10.1038/s42003-024-07009-4 · Cited by 13
“Extensiveresearchsuggeststhat3Dtumorspheroid/organoid modelsareeffectivetoolsforpreclinicaldrugscreeningandveri fi cation 14,15 .”
Wang, J., Deng, Z., Li, X., Zhang, X., Fan, X., & Wang, Y. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00839 · Cited by 13
Non-pooled Human Platelet Lysate: A Potential Serum Alternative for In Vitro Cell Culture
Hesler, M., Kohl, Y., Wagner, S., & von Briesen, H. (2019) · Alternatives to Laboratory Animals · doi:10.1177/0261192919882516 · Cited by 13
“The popularity of 3-D models, such as multicellular tumour spheroids, has been increasing over the years as they exhibit many characteristics of natural tissue and are suitable for the in vitro screening of drugs.(33,34) The 3-D growth of immortalised cells, such as A549 and HepG2, has been well established and these…”
BackgroundA two-compartment bone tumor model to investigate interactions between healthy and tumor cells
Kömez, A., Büyüksungur, A., Antmen, E., Święszkowski, W., Hasırcı, N., & Hasırcı, V. (2020) · Biomedical Materials · doi:10.1088/1748-605x/ab6b31 · Cited by 13
Li, A., & Yang, P. (2020) · Tissue and Cell · doi:10.1016/j.tice.2020.101365 · Cited by 13
Ravera, M., Gabano, E., Zanellato, I., Rangone, B., Perin, E., Ferrari, B., Bottone, M. G., & Osella, D. (2021) · Dalton Transactions · doi:10.1039/d0dt04051g · Cited by 13
Human Serum Enhances Biomimicry of Engineered Tissue Models of Bone and Cancer
Villasante, A., Robinson, S. T., Cohen, A. R., Lock, R. I., Guo, X.-D. E., & Vunjak‐Novakovic, G. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.658472 · Cited by 13
“Unfortunately, these routinely used cytotoxicity/viability assays for 2D cultures failed in 3D systems, and are not easily adapted for 3D cultures studies (Friedrich et al., 2007; Celli et al., 2014; Zanoni et al., 2016).”
BackgroundSmall-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer
Kanabar, D. D., Goyal, M., Kane, E. I., Chavan, T., Kabir, A., Wang, X., Shukla, S. K., Almasri, J., Goswami, S., Osman, G., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00190 · Cited by 13
Das, V., Fürst, T., Gurská, S., Džubák, P., & Hajdúch, M. (2017) · Journal of Visualized Experiments · doi:10.3791/55403 · Cited by 13
Widder, M., Lemke, K., Kekeç, B., Förster, T., Grodrian, A., & Gastrock, G. (2017) · Engineering in Life Sciences · doi:10.1002/elsc.201700008 · Cited by 13
“Zanoni already reviewed, that different 3D cultivation techniques differentially influence the shape of the cultures [24], showing the necessity of being flexible in choosing the right cultivation technique for each cell sample.”
BackgroundDhanwal, V., Katoch, A., Singh, A., Chakraborty, S., Faheem, M. M., Kaur, G., Nayak, D., Singh, N., Goswami, A., & Kaur, N. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.12.039 · Cited by 13
Jong, E. D., Chan, I. C. W., & Nedelcu, A. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00842 · Cited by 13
Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids
Pinto, C. I. G., Branco, A., Bucar, S., Fonseca, A. I., Abrunhosa, A., da Silva, C. L., Guerreiro, J. F., & Mendes, F. (2024) · EJNMMI Research · doi:10.1186/s13550-024-01084-8 · Cited by 12
“Through the promotion of cell-to-cell and cell-to-extracellular matrix (ECM) interactions, spheroids can re-establish the morphological, functional, and mass-transport properties observed in in vivo tumors [17].”
BackgroundReplication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors
Kawachi, A., Lenormand, M. M., Astier, C., Herbel, N., Cutrona, M. B., Duong-Ngo, C., Garrido, M., Eychenne, T., Dorvault, N., Bordelet, L., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3603 · Cited by 12
“As 3D and patient-derived models re-portedly better recapitulate the clinical reality than do 2D cultures or established cell line models (28–30), we sought to develop a new primary patient-derived organoid model of DSRCT.”
Metadata
- Authors
- Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A.
- Affiliations
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- University of Bologna (IT)
- Istituto Ortopedico Rizzoli (IT)
- Corresponding author
- Tesei, Anna
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-01-11
- Volume
- 6
- Issue
- 1
- Pages
- 19103-19103
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4707510
- OpenAlex
- W2236643502
- Cited by
- 1,144
- References
- 43
- Citations by year
- 2026: 97 · 2025: 127 · 2024: 124 · 2023: 105 · 2022: 112 · 2021: 117 · 2020: 138 · 2019: 118 · 2018: 118 · 2017: 70 · 2016: 17
- FWCI
- 57.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Funders
- Ministero della Salute
- Istituto Ortopedico Rizzoli di Bologna
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- tumor spheroids, spheroid morphology, automated image analysis, viability assay, cytotoxicity assay
- MeSH terms
- Cell Survival, Drug Screening Assays, Antitumor, Fibroblasts, Humans, Models, Biological, Tumor Cells, Cultured, Reproducibility of Results, Spheroids, Cellular, Imaging, Three-Dimensional, Cell Shape
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.